<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087747</url>
  </required_header>
  <id_info>
    <org_study_id>AChol</org_study_id>
    <nct_id>NCT03087747</nct_id>
  </id_info>
  <brief_title>Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes</brief_title>
  <official_title>Percutaneous Drainage in a Setting of Acute Cholecystitis Severity Grade III and Correlation With Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Split, School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Split, School of Medicine</source>
  <brief_summary>
    <textblock>
      In a setting of acute cholecystitis (AC) one of the treatment option is percutaneous
      transhepatic cholangiography (PTHC) drainage. The goal of current study is to evaluate some
      radiology aspects and correlate with clinical patient outcomes in patients with acute
      cholecystitis severity grade III (presented as acute cholecystitis with organ dysfunction).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>C-reactive protein (CRP)</measure>
    <time_frame>Up to 8 weeks.</time_frame>
    <description>C-reactive protein (CRP) is a protein found in blood plasma, whose levels rise in response to inflammation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drainage duration (expressed in days)</measure>
    <time_frame>Up to 16 weeks.</time_frame>
    <description>The drain which is placed in gallbladder during Percutaneous transhepatic cholangiography (PTHC) remains there until resolving clinical parameters of acute cholecystitis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cells (WBCs) count</measure>
    <time_frame>Up to 8 weeks.</time_frame>
    <description>White blood cells (WBCs) are the cells of the immune system. During inflammation White blood cell level rise.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cholecystitis, Acute</condition>
  <condition>Elderly Infection</condition>
  <condition>Drain Abscess</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients older than 80 yr. Clinical parameters after percutaneous transhepatic cholangiography (PTHC).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients younger than 80 yr. Clinical parameters after percutaneous transhepatic cholangiography (PTHC).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous cholecystostomy</intervention_name>
    <description>Placement of drainage catheter into gallbladder lumen in order to evacuate inflamed content.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute cholecystitis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical markers of acute cholecystitis

          -  diagnosis confirmed with some imaging technique: computed tomography (CT), ultrasound
             (US).

        Exclusion Criteria:

          -  clinical diagnosis was not confirmed with imaging.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Liana Cambj Sapunar, Professor</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Split</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antonia Bralic, MD</last_name>
    <phone>+38521556265</phone>
    <email>antonia.scepanovic@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marija Cavar</last_name>
    <phone>+38521556265</phone>
    <email>marija.cavar@mefst.hr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Split, School of Medicine</name>
      <address>
        <city>Split</city>
        <zip>21000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marija Cavar, MD</last_name>
      <phone>385 21 556265</phone>
      <email>marija.cavar@mefst.hr</email>
    </contact>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Split, School of Medicine</investigator_affiliation>
    <investigator_full_name>Marija Cavar</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecystitis</mesh_term>
    <mesh_term>Acalculous Cholecystitis</mesh_term>
    <mesh_term>Cholecystitis, Acute</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

